16.95
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IMVT Giù?
Forum
Previsione
Precedente Chiudi:
$18.32
Aprire:
$16.32
Volume 24 ore:
4.51M
Relative Volume:
3.56
Capitalizzazione di mercato:
$2.90B
Reddito:
-
Utile/perdita netta:
$-382.71M
Rapporto P/E:
-6.4695
EPS:
-2.62
Flusso di cassa netto:
$-325.64M
1 W Prestazione:
-5.36%
1M Prestazione:
+7.62%
6M Prestazione:
-26.46%
1 anno Prestazione:
-39.03%
Immunovant Inc Stock (IMVT) Company Profile
Nome
Immunovant Inc
Settore
Industria
Telefono
917-580-3099
Indirizzo
320 WEST 37TH STREET, NEW YORK, NY
Confronta IMVT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
IMVT
Immunovant Inc
|
16.95 | 3.13B | 0 | -382.71M | -325.64M | -2.62 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunovant Inc Stock (IMVT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-10 | Ripresa | Goldman | Neutral |
2025-03-03 | Iniziato | Jefferies | Hold |
2025-01-03 | Downgrade | Wolfe Research | Outperform → Peer Perform |
2024-10-10 | Ripresa | Raymond James | Outperform |
2024-10-09 | Reiterato | Oppenheimer | Outperform |
2024-03-28 | Iniziato | Oppenheimer | Outperform |
2024-03-13 | Iniziato | Goldman | Buy |
2024-02-20 | Iniziato | JP Morgan | Overweight |
2024-02-15 | Iniziato | Wolfe Research | Outperform |
2023-12-12 | Iniziato | Deutsche Bank | Buy |
2023-10-13 | Aggiornamento | UBS | Neutral → Buy |
2023-09-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2023-05-01 | Iniziato | BofA Securities | Buy |
2023-04-25 | Iniziato | Citigroup | Buy |
2023-03-31 | Iniziato | Piper Sandler | Overweight |
2023-03-30 | Iniziato | Stifel | Buy |
2023-02-15 | Iniziato | Cantor Fitzgerald | Overweight |
2023-02-13 | Aggiornamento | Guggenheim | Neutral → Buy |
2023-01-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2022-09-26 | Downgrade | UBS | Buy → Neutral |
2021-12-08 | Iniziato | Wells Fargo | Equal Weight |
2021-08-03 | Downgrade | Robert W. Baird | Outperform → Neutral |
2021-08-02 | Downgrade | Credit Suisse | Neutral → Underperform |
2021-06-01 | Downgrade | Guggenheim | Buy → Neutral |
2021-06-01 | Downgrade | Stifel | Buy → Hold |
2020-10-28 | Iniziato | UBS | Buy |
2020-10-12 | Iniziato | Guggenheim | Buy |
2020-10-08 | Iniziato | Stifel | Buy |
2020-10-02 | Iniziato | Credit Suisse | Outperform |
2020-08-26 | Reiterato | H.C. Wainwright | Buy |
2020-08-25 | Iniziato | Raymond James | Outperform |
2020-07-29 | Iniziato | H.C. Wainwright | Buy |
2020-02-24 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Immunovant Inc Borsa (IMVT) Ultime notizie
Bank of New York Mellon Corp Reduces Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Immunovant Executives Sell Shares to Cover Tax Obligations - TradingView
Can Immunovant Inc. stock recover from recent declineHigh-profit stock alerts - jammulinksnews.com
LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT - MSN
Is Immunovant Inc. a good long term investmentExceptional gains - PrintWeekIndia
What drives Immunovant Inc. stock priceHigh-profit stock alerts - Autocar Professional
What analysts say about Immunovant Inc. stockTremendous wealth creation - Autocar Professional
Why Immunovant Inc. stock attracts strong analyst attentionFree Daily Stock Market Updates - Newser
How high can Immunovant Inc. stock price go in 2025Free Smart Trading Workshop - jammulinksnews.com
Immunovant, Inc. (NASDAQ:IMVT) Shares Purchased by Arizona State Retirement System - Defense World
Immunovant Inc. Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com
Teacher Retirement System of Texas Buys 2,919 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World
why immunovant inc. stock attracts strong analyst attentionFree Access to Community - Newser
September 19th Options Now Available For Immunovant (IMVT) - Nasdaq
(IMVT) Trading Advice - news.stocktradersdaily.com
All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy - Yahoo Finance
Goldman Sachs Resumes Coverage of Immunovant (IMVT) with a Hold Rating - MSN
Wall Street Analysts See a 137.68% Upside in Immunovant (IMVT): Can the Stock Really Move This High? - Yahoo Finance
12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey
What makes Immunovant Inc. stock price move sharplyShort Squeeze Radar - Newser
How Immunovant Inc. stock performs during market volatilityFree Trading Strategy Suggestions - Newser
Principal Financial Group Inc. Sells 31,255 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World
The Goldman Sachs Group Upgrades Immunovant (NASDAQ:IMVT) to Hold - Defense World
Immunovant (IMVT) chief technology officer Stout sells $26k in stock - Investing.com Australia
Goldman Sachs resumes Immunovant stock coverage with Neutral rating By Investing.com - Investing.com Canada
Immunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Immunovant, Inc. (NASDAQ:IMVT) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World
(IMVT) Technical Data - news.stocktradersdaily.com
How to Take Advantage of moves in (IMVT) - news.stocktradersdaily.com
Immunovant Inc Azioni (IMVT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):